Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Sanborn J.,,Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons,2013,Cancer Research,47,10.1158/0008-5472.CAN-13-0186,United States;United States,Article,Santa Cruz;Santa Cruz,1,Journal,2-s2.0-84885074156
Zheng S.,,A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival,2013,Genes and Development,44,10.1101/gad.213686.113,United States,Article,Houston,1,Journal,2-s2.0-84879764400
Lawrence M.S.,,Mutational heterogeneity in cancer and the search for new cancer-associated genes,2013,Nature,2675,10.1038/nature12213,United States,Article,Cambridge,0,Journal,2-s2.0-84880507665
Killela P.,,TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal,2013,Proceedings of the National Academy of Sciences of the United States of America,766,10.1073/pnas.1303607110,United States,Article,Durham,1,Journal,2-s2.0-84876067164
Costello M.,,Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation,2013,Nucleic Acids Research,198,10.1093/nar/gks1443,United States,Article,Cambridge,1,Journal,2-s2.0-84876020288
Kannan K.,,Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma,2012,Oncotarget,170,,United States,Article,New York,0,Journal,2-s2.0-84872788316
Liu X.,,Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations,2012,Acta Neuropathologica,222,10.1007/s00401-012-1031-3,Canada,Article,Montreal,0,Journal,2-s2.0-84871020024
Dolecek T.,,CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009,2012,Neuro-Oncology,1072,10.1093/neuonc/nos218,,Review,,1,Journal,2-s2.0-84868023931
Sturm D.,,Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma,2012,Cancer Cell,940,10.1016/j.ccr.2012.08.024,Germany,Article,Heidelberg,1,Journal,2-s2.0-84867606428
Koboldt D.C.,,Comprehensive molecular portraits of human breast tumours,2012,Nature,6015,10.1038/nature11412,United States,Article,St. Louis,1,Journal,2-s2.0-84877028141
Hammerman P.S.,,Comprehensive genomic characterization of squamous cell lung cancers,2012,Nature,2233,10.1038/nature11404,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-84866894408
Imielinski M.,,Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing,2012,Cell,1090,10.1016/j.cell.2012.08.029,United States;United States;United States;United States,Article,Boston;Boston;Boston;Cambridge,1,Journal,2-s2.0-84866410479
Singh D.,,Transforming fusions of FGFR and TACC genes in human glioblastoma,2012,Science,425,10.1126/science.1220834,United States,Article,New York,0,Journal,2-s2.0-84865805666
Hodis E.,,A landscape of driver mutations in melanoma,2012,Cell,1470,10.1016/j.cell.2012.06.024,United States;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-84864258996
Muzny D.M.,,Comprehensive molecular characterization of human colon and rectal cancer,2012,Nature,4331,10.1038/nature11252,United States,Article,Houston,1,Journal,2-s2.0-84863922124
Chen A.,,STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA,2012,Genes and Development,69,10.1101/gad.189001.112,United States,Article,Boston,1,Journal,2-s2.0-84863661316
Lovejoy C.A.,,"Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of Telomeres pathway",2012,PLoS Genetics,314,10.1371/journal.pgen.1002772,United States,Article,New York,1,Journal,2-s2.0-84864619205
Berger M.F.,,Melanoma genome sequencing reveals frequent PREX2 mutations,2012,Nature,485,10.1038/nature11071,United States;United States,Article,New York;Cambridge,1,Journal,2-s2.0-84861427327
Vivanco I.,,Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors,2012,Cancer Discovery,197,10.1158/2159-8290.CD-11-0284,United States,Article,New York,1,Journal,2-s2.0-84861760527
Carter S.L.,,Absolute quantification of somatic DNA alterations in human cancer,2012,Nature Biotechnology,836,10.1038/nbt.2203,United States;United States,Article,Cambridge;Cambridge,1,Journal,2-s2.0-84860782006
Dunn G.,,Emerging insights into the molecular and cellular basis of glioblastoma,2012,Genes and Development,339,10.1101/gad.187922.112,United States;United States;United States,Article,Boston;Boston;Cambridge,1,Journal,2-s2.0-84859847164
Holmes K.,,"Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-ÎºB network",2012,Proceedings of the National Academy of Sciences of the United States of America,74,10.1073/pnas.1120375109,United States,Article,Houston,1,Journal,2-s2.0-84863261004
Szerlip N.J.,,Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response,2012,Proceedings of the National Academy of Sciences of the United States of America,304,10.1073/pnas.1114033109,United States,Article,Detroit,1,Journal,2-s2.0-84857397985
Schwartzentruber J.,,Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma,2012,Nature,1276,10.1038/nature10833,Canada,Article,Montreal,0,Journal,2-s2.0-84862777348
Ciriello G.,,Mutual exclusivity analysis identifies oncogenic network modules,2012,Genome Research,368,10.1101/gr.125567.111,United States,Article,New York,1,Journal,2-s2.0-84856535081
Bady P.,,"MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status",2012,Acta Neuropathologica,160,10.1007/s00401-012-1016-2,Switzerland;Switzerland,Article,Geneva;Lausanne,1,Journal,2-s2.0-84866542816
Wang L.,,SF3B1 and other novel cancer genes in chronic lymphocytic leukemia,2011,New England Journal of Medicine,764,10.1056/NEJMoa1109016,United States,Article,Boston,0,Journal,2-s2.0-84855370035
Cho J.,,Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies,2011,Cancer Research,50,10.1158/0008-5472.CAN-11-0821,South Korea;United States,Article,Seoul;Boston,1,Journal,2-s2.0-84255170397
Snuderl M.,,Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma,2011,Cancer Cell,415,10.1016/j.ccr.2011.11.005,United States,Article,Boston,1,Journal,2-s2.0-83455176258
Sumazin P.,,An extensive MicroRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma,2011,Cell,497,10.1016/j.cell.2011.09.041,United States,Article,New York,1,Journal,2-s2.0-80054689794
Tay Y.,,Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs,2011,Cell,704,10.1016/j.cell.2011.09.029,United States,Article,Boston,1,Journal,2-s2.0-80054700538
Bass A.,,Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion,2011,Nature Genetics,229,10.1038/ng.936,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-80053385552
Stransky N.,,The mutational landscape of head and neck squamous cell carcinoma,2011,Science,1512,10.1126/science.1208130,United States,Article,Cambridge,0,Journal,2-s2.0-80052158097
Bell D.,,Integrated genomic analyses of ovarian carcinoma,2011,Nature,4070,10.1038/nature10166,United States,Article,Rochester,1,Journal,2-s2.0-79959838081
Chapman P.B.,,Improved survival with vemurafenib in melanoma with BRAF V600E mutation,2011,New England Journal of Medicine,5313,10.1056/NEJMoa1103782,United States,Article,New York,0,Journal,2-s2.0-79959795786
Depristo M.,,A framework for variation discovery and genotyping using next-generation DNA sequencing data,2011,Nature Genetics,5321,10.1038/ng.806,United States,Article,Cambridge,0,Journal,2-s2.0-79955483667
Mermel C.,,GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers,2011,Genome Biology,1010,10.1186/gb-2011-12-4-r41,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-79955166265
Chapman M.A.,,Initial genome sequencing and analysis of multiple myeloma,2011,Nature,976,10.1038/nature09837,United Kingdom;United States,Article,Cambridge;Cambridge,1,Journal,2-s2.0-79951494668
Zheng S.,,DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression,2011,Neuro-Oncology,47,10.1093/neuonc/noq190,United States,Article,San Francisco,1,Journal,2-s2.0-79955765058
Varela I.,,Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma,2011,Nature,858,10.1038/nature09639,United Kingdom,Article,Hinxton,0,Journal,2-s2.0-79251635938
Fisher S.,,"A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries",2011,Genome Biology,231,10.1186/gb-2011-12-1-r1,United States,Article,Cambridge,1,Journal,2-s2.0-78650762588
Wiegand K.,,ARID1A mutations in endometriosis-associated ovarian carcinomas,2010,New England Journal of Medicine,1044,10.1056/NEJMoa1008433,Canada;Canada,Article,Vancouver;Vancouver,0,Journal,2-s2.0-77957946398
Ozawa T.,,PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas,2010,Genes and Development,129,10.1101/gad.1972310,United States,Article,New York,1,Journal,2-s2.0-77957667714
Krol J.,,"The widespread regulation of microRNA biogenesis, function and decay",2010,Nature Reviews Genetics,2796,10.1038/nrg2843,Switzerland,Review,Basel,0,Journal,2-s2.0-77955902024
Inda M.D.M.,,Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma,2010,Genes and Development,347,10.1101/gad.1890510,United States,Article,San Diego,1,Journal,2-s2.0-77955911497
Noushmehr H.,,Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma,2010,Cancer Cell,1466,10.1016/j.ccr.2010.03.017,United States,Article,Los Angeles,1,Journal,2-s2.0-77952108366
Beroukhim R.,,The landscape of somatic copy-number alteration across human cancers,2010,Nature,2144,10.1038/nature08822,United States;United States;United States;United States,Article,Cambridge;Boston;Boston;Boston,0,Journal,2-s2.0-77249119762
Verhaak R.G.W.,,"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1",2010,Cancer Cell,3807,10.1016/j.ccr.2009.12.020,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-73649123907
Schittenhelm J.,,Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival,2009,Modern Pathology,18,10.1038/modpathol.2009.132,Germany,Article,Tubingen,1,Journal,2-s2.0-71149088947
Brennan C.,,Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations,2009,PLoS ONE,366,10.1371/journal.pone.0007752,United States,Article,New York,1,Journal,2-s2.0-70849122697
Chen K.,,BreakDancer: An algorithm for high-resolution mapping of genomic structural variation,2009,Nature Methods,880,10.1038/nmeth.1363,United States,Article,St. Louis,0,Journal,2-s2.0-69549116107
Ichimura K.,,IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas,2009,Neuro-Oncology,441,10.1215/15228517-2009-025,United Kingdom;United Kingdom,Article,Cambridge;Cambridge,1,Journal,2-s2.0-68349116524
Park S.Y.,,miR-29 miRNAs activate p53 by targeting p85Î± and CDC42,2009,Nature Structural and Molecular Biology,487,10.1038/nsmb.1533,South Korea,Article,Seoul,0,Journal,2-s2.0-58149215802
Friedman R.,,Most mammalian mRNAs are conserved targets of microRNAs,2009,Genome Research,5184,10.1101/gr.082701.108,United States;United States,Article,Cambridge;Chevy Chase,1,Journal,2-s2.0-60149095444
McLendon R.,,Comprehensive genomic characterization defines human glioblastoma genes and core pathways,2008,Nature,4803,10.1038/nature07385,United States,Article,Durham,1,Journal,2-s2.0-54549108740
Korn J.,,"Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs",2008,Nature Genetics,591,10.1038/ng.237,United States;United States;United States;United States,Article,Cambridge;Boston;Cambridge;Cambridge,0,Journal,2-s2.0-52949085789
McCarroll S.A.,,Integrated detection and population-genetic analysis of SNPs and copy number variation,2008,Nature Genetics,713,10.1038/ng.238,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-52949141845
Wiedemeyer R.,,Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development,2008,Cancer Cell,102,10.1016/j.ccr.2008.02.010,United States,Article,Boston,1,Journal,2-s2.0-41449108880
Betel D.,,The microRNA.org resource: Targets and expression,2008,Nucleic Acids Research,1730,10.1093/nar/gkm995,United States,Article,New York,1,Journal,2-s2.0-38549124383
Parmigiani G.,,"Response to comments on ""The consensus coding sequences of human breast and colorectal cancers""",2007,Science,59,10.1126/science.1138773,United States,Note,Baltimore,0,Journal,2-s2.0-34548677928
Grimson A.,,MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing,2007,Molecular Cell,2720,10.1016/j.molcel.2007.06.017,United States;United States,Article,Cambridge;Cambridge,1,Journal,2-s2.0-34250805982
Venkatraman E.,,A faster circular binary segmentation algorithm for the analysis of array CGH data,2007,Bioinformatics,601,10.1093/bioinformatics/btl646,United States,Article,New York,1,Journal,2-s2.0-34147104969
Kuttler F.,,"Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis",2007,Seminars in Cancer Biology,56,10.1016/j.semcancer.2006.10.007,Canada,Review,Winnipeg,0,Journal,2-s2.0-33846026008
Ohgaki H.,,Genetic pathways to primary and secondary glioblastoma,2007,American Journal of Pathology,942,10.2353/ajpath.2007.070011,France,Review,Lyon,0,Journal,2-s2.0-34250877865
Chen K.,,Natural selection on human microRNA binding sites inferred from SNP data,2006,Nature Genetics,347,10.1038/ng1910,United States,Article,New York,0,Journal,2-s2.0-33751520430
Phillips H.,,"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis",2006,Cancer Cell,1952,10.1016/j.ccr.2006.02.019,United States,Article,San Francisco,1,Journal,2-s2.0-33644820339
Krek A.,,Combinatorial microRNA target predictions,2005,Nature Genetics,3564,10.1038/ng1536,United States,Article,New York,0,Journal,2-s2.0-20944450160
Hegi M.,,MGMT gene silencing and benefit from temozolomide in glioblastoma,2005,New England Journal of Medicine,4306,10.1056/NEJMoa043331,Switzerland;Switzerland,Article,Lausanne;Epalinges,0,Journal,2-s2.0-20044372154
Lewis B.P.,,"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets",2005,Cell,8815,10.1016/j.cell.2004.12.035,United States;United States,Letter,Cambridge;Cambridge,1,Journal,2-s2.0-11844278458
John B.,,Human microRNA targets,2004,PLoS Biology,2538,10.1371/journal.pbio.0020363,United States,Article,New York,1,Journal,2-s2.0-14044251458
Bartel D.,,"MicroRNAs: Genomics, Biogenesis, Mechanism, and Function",2004,Cell,25016,10.1016/S0092-8674(04)00045-5,United States;United States,Review,Cambridge;Cambridge,1,Journal,2-s2.0-0347444723
Shono T.,,Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations,2001,Cancer Research,266,,United States,Article,Houston,0,Journal,2-s2.0-0035360795
Kurahashi H.,,Isolation and characterization of a novel gene deleted in digeorge syndrome,1995,Human Molecular Genetics,50,10.1093/hmg/4.4.541,Japan,Article,Suita,0,Journal,2-s2.0-0028915336
Callaghan T.,,A complete description of the EGF-receptor exon structure: Implication in oncogenic activation and domain evolution,1993,Oncogene,42,,United States,Article,Cleveland,0,Journal,2-s2.0-0027527914
